Stryker Corporation (BVMF:S1YK34)
97.00
-1.00 (-1.02%)
Last updated: Dec 4, 2025, 11:34 AM GMT-3
Stryker Revenue
Stryker had revenue of $6.06B USD in the quarter ending September 30, 2025, with 10.25% growth. This brings the company's revenue in the last twelve months to $24.38B, up 10.95% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$24.38B
Revenue Growth
+10.95%
P/S Ratio
5.68
Revenue / Employee
$460.02K
Employees
53,000
Market Cap
738.31B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |